Table 3.
Exploratory baseline-to-final changes in psychological and physical health outcomes.
|
|
Exercise (n=4) | Control (n=2) | ||
| Variables | Baseline median (min-max)a | Final median (min-max) | Baseline median (min-max) | Final median (min-max) |
| Depression | 2.5 (1-13) | 7.5 (2-13) | 15 (8-22) | 9.5 (7-12) |
| Anxiety | 3 (1-12) | 6 (2-20) | 15.5 (15-16) | 12 (11-13) |
| Stigma | 2.9 (1-4.7) | 2.5 (1-5.6) | 3.3 (3.2-3.4) | 3.8 (3.6-3.9) |
| General self-efficacy | 3.6 (2.5-4.1) | 3.5 (3.4-4) | 2.9 (1.8-4) | 3.4 (3.1-3.8) |
| Sleep | 5.5 (4-10) | 7 (2-9) | 9.5 (3-16) | 10.5 (4-17) |
| VO2 max (ml/kg/min) | 39.1 (21-54.4) | 39.9 (23.9-50.2) | 36.3 (32-40.7) | 35.9 (32.8-39.1) |
| Weight (lbs) | 175.5 (148.5-211.8) | 172.9 (153.8-211.4) | 136 (135-137) | 130.2 (128-132.4) |
| BMI (kg/m2) | 24.9 (22.1-36.8) | 24.5 (22.9-37.4) | 21.4 (21.4-21.5) | 20.9 (20.1-21.6) |
| Body fat % | 16 (10.2-41) | 16.7 (11.3-42.1) | 22.4 (21.9-22.9) | 20.9 (18.9-22.9) |
| Habit Index | ||||
| Instigation subscale | 1.5 (1-3) | 3 (2-3.3) | 1.3 (1-1.7) | 1 (1-1) |
| Preparation subscale | 3.5 (1-4) | 3.3 (2.3-4.3) | 1.5 (1.3-1.7) | 1 (1-1) |
| QOLIE-31b | ||||
| Seizure worry | 79.3 (68.7-95) | 86.3 (28.7-96) | 54.7 (36.7-72.6) | 54.5 (27.3-81.7) |
| Overall QOL | 72.5 (40-77.5) | 71.3 (27.5-77.5) | 57.5 (37.5-77.5) | 63.8 (60-67.5) |
| Emotional well-being | 58 (36-88) | 58 (28-80) | 40 (24-56) | 56 (52-60) |
| Medication effects | 54.2 (33.3-88.9) | 23.6 (0-100) | 66.7 (61.1-72.3) | 69.5 (50-88.9) |
| Energy and fatigue | 47.5 (30-75) | 45 (10-55) | 30 (10-50) | 45 (35-55) |
| Cognitive function | 36.2 (10-80) | 43.6 (3.3-93.3) | 24.3 (19.7-28.9) | 37.6 (25.6-49.7) |
| Social function | 93 (81-100) | 92.5 (28-100) | 65 (35-95) | 78.5 (62-95) |
| Total QOLIE-31 | 64 (39.8-81.5) | 63.7 (18.6-81.8) | 44.2 (30.7-57.8) | 55.6 (48.9-62.2) |
aData are presented as median (minimum-maximum) because of the small group sample size.
bQOLIE-31: Quality of Life in Epilepsy Inventory-31.